phosphorus has been researched along with calcium acetate in 32 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (calcium acetate) | Trials (calcium acetate) | Recent Studies (post-2010) (calcium acetate) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 194 | 41 | 77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (59.38) | 29.6817 |
| 2010's | 13 (40.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R | 1 |
| Gropper, SS; Soffer, O; Yates, LA | 1 |
| Heicappell, R; Miller, K; Müller, M; Schrader, M; Straub, B | 1 |
| Malluche, HH; Mawad, H | 1 |
| Cerezo, S; Hervás, JG; Prados, D | 1 |
| Neme, G; Peñalba, A; Tirado, S | 1 |
| Nolan, CR; Qunibi, WY | 2 |
| Paret, CL | 1 |
| Cleveland, MV; Garza, RO; He, DY; Hootkins, RE; McDowell, LL; Meyer, MS; Muenz, LR; Nolan, CR; Pelham, RW; Qunibi, WY; Simon, M | 1 |
| González, A; Martín, F; Martínez, F; Sarró, F; Verdú, J | 1 |
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Drüeke, TB; Landais, P | 1 |
| Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
| Chou, CY; Huang, CC; Kuo, HL; Liao, PY; Lin, HH; Lin, PW; Liu, JH; Liu, YL; Yang, YF; Yu, CC | 1 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Caputo, F; Chasan-Taber, S; Duggal, A; Evenepoel, P; Fan, S; Foggensteiner, L; Heaf, JG; Kelly, A; Ortiz, A; Selgas, R | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Gotch, F; Kotanko, P; Levin, NW | 1 |
| Benedyk-Lorens, E; Covic, AC; de Francisco, AL; Ketteler, M; Leidig, M; Mircescu, GM; Passlick-Deetjen, J; Ponce, P; Scholz, C | 1 |
| Noto, L | 1 |
| Álvarez-Ude, F; Arenas, MD; Gil, MT; Malek, T; Moledous, A; Reig-Ferrer, A | 1 |
| Bondor, C; Brumboiu, A; Gherman-Caprioara, M; Kacso, I; Moldovan, D; Moldovan, I; Orasan, R; Parvu, L; Patiu, IM; Racasan, S; Rusu, C | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Diaz-Buxo, JA; Greenberg, J; Ho, CH; Kessler, P; Moustafa, M; Qunibi, W; Solomon, R; Winkelmayer, WC | 1 |
| Huml, AM; Leon, JB; Sehgal, AR; Sullivan, CM | 1 |
| Abad, S; Arroyo, D; López-Gómez, JM; Panizo, N; Pérez-de José, A; Vega, A | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Castanheira, L; Celis, JP; Chakar, C; Changotade, S; Felgueiras, HP; Henriques, M; Lutomski, D; Migonney, V; Naaman, N; Oughlis, S; Poirier, F; Ponthiaux, P; Rocha, LA; Younes, R | 1 |
| Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
| Guo, X; Liu, X; Liu, Z; Ma, W; Su, G; Wu, Y; Xu, Y; Yang, Q; Zhang, L; Zou, C | 1 |
7 review(s) available for phosphorus and calcium acetate
| Article | Year |
|---|---|
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.
Topics: Acetates; Calcium Compounds; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders | 2002 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Topics: Acetates; Calcium; Calcium Compounds; Double-Blind Method; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis | 2004 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
Topics: Acetates; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Bread; Calcium; Calcium Compounds; Calcium Phosphates; Calcium, Dietary; Dietary Proteins; Fibroblast Growth Factor-23; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2015 |
9 trial(s) available for phosphorus and calcium acetate
| Article | Year |
|---|---|
Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Compounds; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).
Topics: Acetates; Adult; Aged; Bicarbonates; Calcium; Calcium Compounds; Double-Blind Method; Epoxy Compounds; Female; Humans; Hypercalcemia; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Prospective Studies; Renal Dialysis; Sevelamer | 2004 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Remodeling; Calcium; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Research Design; Sevelamer; Treatment Outcome | 2006 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Topics: Acetates; Adult; Aged; Calcium Compounds; Chelating Agents; Drug Tolerance; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Polyamines; Sevelamer | 2009 |
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium Compounds; Female; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.
Topics: Acetates; Calcium; Calcium Compounds; Chelating Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2011 |
16 other study(ies) available for phosphorus and calcium acetate
| Article | Year |
|---|---|
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2000 |
Phosphate binders do not compromise the copper status of adult renal disease patients on hemodialysis.
Topics: Acetates; Adult; Aged; Aluminum Hydroxide; Antacids; Calcium Carbonate; Calcium Compounds; Ceruloplasmin; Copper; Erythrocytes; Female; Humans; Male; Middle Aged; Nutritional Physiological Phenomena; Phosphorus; Renal Dialysis; Renal Insufficiency; Superoxide Dismutase | 2000 |
Osteoporosis and mild metabolic acidosis in the rat after orchiectomy and their prevention: should prophylactic therapy be administered to patients with androgen deprivation?
Topics: Acetates; Acidosis; Androgens; Animals; Bone and Bones; Bone Density; Calcium; Calcium Compounds; Citrates; Femoral Fractures; Hydrogen-Ion Concentration; Intestinal Absorption; Magnesium; Male; Orchiectomy; Osteoporosis; Phosphorus; Rats; Rats, Sprague-Dawley; Sodium Citrate; Stress, Mechanical | 2001 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
[MIBI and parathyroid gland function in secondary hyperparathyroidism].
Topics: Acetates; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Secretory Rate; Technetium Tc 99m Sestamibi; Uremia | 2004 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
[Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control].
Topics: Acetates; Aged; Aluminum Hydroxide; Calcium Compounds; Chelating Agents; Chelation Therapy; Cohort Studies; Cross-Sectional Studies; Dyspepsia; Female; Health Knowledge, Attitudes, Practice; Humans; Lanthanum; Male; Middle Aged; Patient Compliance; Patient Preference; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Tablets; Taste | 2010 |
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Risk Factors; Serum Albumin; Sex Factors; Vascular Calcification | 2011 |
The adequacy of phosphorus binder prescriptions among American hemodialysis patients.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; United States | 2012 |
The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.
Topics: Acetates; Aluminum Hydroxide; Calcium Compounds; Drug Substitution; Female; Humans; Magnesium; Male; Middle Aged; Phosphorus; Renal Dialysis | 2014 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Biotribocorrosion (tribo-electrochemical) characterization of anodized titanium biomaterial containing calcium and phosphorus before and after osteoblastic cell culture.
Topics: Acetates; Alkaline Phosphatase; Bone Neoplasms; Calcium Compounds; Cell Differentiation; Cell Line, Tumor; Cell Shape; Coated Materials, Biocompatible; Corrosion; Dental Materials; Electrochemistry; Friction; Glycerophosphates; Humans; Hydrophobic and Hydrophilic Interactions; Materials Testing; Osseointegration; Osteoblasts; Osteosarcoma; Oxidation-Reduction; Oxides; Phosphates; Phosphorus; Titanium | 2015 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |